More Articles
It has long been believed that men face a higher risk of developing atrial fibrillation (AFib) than women. A new study published in JAMA Cardiology, however, flips the script on that very notion, suggesting that the risk is…
Medtronic shared some good news with attendees at ESC Congress 2022 in Barcelona, the annual meeting of the European Society of Cardiology, noting that its Extravascular Implantable Cardioverter…
ESC Congress 2022, the annual meeting of the European Society of Cardiology, was jam-packed with eye-opening new research from many of the leading voices in cardiovascular and vascular medicine…
Treating elderly atrial fibrillation (AFib) patients—even those who are traditionally ineligible for direct oral anticoagulants (DOACs)—with a very low dose of edoxaban is associated with improved outcomes, according to new research…
Thinking has changed: Cardiac implantable electronic device (CIED) infections are a bigger deal than we thought.
The latest research supports a new approach to who and how we treat…
Patients prescribed cannabis for chronic pain may face a heightened risk of experiencing heart rhythm issues, according to new research to be presented at…
The U.S. Food and Drug Administration (FDA) has announced that Medtronic is recalling 87,709 implantable cardiac devices due to the risk of a malfunction that could result in serious injury or death…
CathVision, a Denmark-based healthcare technology company focused on the electrophysiology (EP) lab, has closed a new financing round worth $7.2 million.…
Monitoring patient symptoms is an essential part of diagnosing and treating cardiovascular disease (CVD). A new scientific statement from the American Heart Association (AHA), published in …
Atrial cardiomyopathy is associated with an increased risk of dementia among older adults, according to new research published in the Journal of the American Heart Association.[1]
“Stroke…
In a massive simulation exercise, researchers recently found that using wrist-worn wearable devices to screen people for atrial fibrillation (AFib) may be more cost-effective than traditional modalities such as pulse palpation and 12-…
The risk of in-hospital mortality may be significantly higher among transcatheter edge-to-edge repair (TEER) patients who present with concomitant…
There is not agreement among some of the top structural heart experts who perform left atrial appendage occlusion (LAAO) if cardiac computed tomography (CT…
The U.S. Food and Drug Administration (FDA) has had a busy in July, approving…
Patients with heart failure or…
The KardiaBand device from AliveCor is a more reliable tool for identifying atrial fibrillation (AFib) than the…
Patients with a history of atrial fibrillation (AFib) are more likely to experience adverse outcomes within two years of transcatheter…
When the first catheter-implanted, leadless pacemaker was introduced in 2016, there was a lot of interest in this minimally invasive technology. But the biggest criticism was that it only addressed the needs of about 20% of patients. However, 100…
Catheter ablation is an "economically attractive" treatment option for atrial fibrillation (AFib) when compared to antiarrhythmic drug therapy alone,, according to a new study in …
Patients who develop atrial fibrillation (AFib) after surgery face a higher risk of being hospitalized for heart failure, according to new data published in the European Heart Journal.[1]
The…